Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Jennifer Rachel Eads

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0491-4518; OpenAlex author ID A5076392900. Sources: ClinicalTrials.gov.

Their work

Papers
4
Trials
2 (principal investigator on 2)
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2014: 1 trial · 2015: none · 2016: 2 papers, 1 trial · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 4

  1. Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41467-024-49915-5↗
  2. Multianalyte Prognostic Signature Including Circulating Tumor DNA and Circulating Tumor Cells in Patients With Advanced Pancreatic Adenocarcinoma. Co-author DOI 10.1200/po.22.00060↗
  3. Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. Co-author DOI 10.1200/jco.2016.67.5561↗
  4. The role of neoadjuvant therapy in pancreatic cancer: a review. Co-author DOI 10.2217/fon.15.335↗

Trials 2

  1. Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer Principal investigator NCT02383433↗
  2. Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery Principal investigator NCT01954732↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Peter James O'Dwyer · 2 shared papers, 2022–2024 · strength 0.25
  2. Thomas Benjamin Karasic · 2 shared papers, 2022–2024 · strength 0.25
  3. Jacob Edward Till · 2 shared papers, 2022–2024 · strength 0.25
  4. Erica L. Carpenter · 2 shared papers, 2022–2024 · strength 0.25
  5. Mark H. O’Hara · 2 shared papers, 2022–2024 · strength 0.25
  6. Kim A. Reiss · 2 shared papers, 2022–2024 · strength 0.25
  7. Davendra Sohal · 1 shared trial, 2016 · strength 0.19
  8. Andrew H. Ko · 2 shared papers, 2016–2024 · strength 0.18
  9. Neha Bhagwat · 1 shared paper, 2024 · strength 0.13
  10. Zev A. Wainberg · 1 shared paper, 2024 · strength 0.13
  11. Samuele Cannas · 1 shared paper, 2024 · strength 0.13
  12. Robert A. Wolff · 1 shared paper, 2024 · strength 0.13
  13. Eileen Mary O'Reilly · 1 shared paper, 2024 · strength 0.13
  14. Lacey Padrón · 1 shared paper, 2024 · strength 0.13
  15. Robert H. Vonderheide · 1 shared paper, 2024 · strength 0.13
  16. George Albert Fisher · 1 shared paper, 2024 · strength 0.13
  17. Osama E. Rahma · 1 shared paper, 2024 · strength 0.13
  18. William Joseph Chapin · 1 shared paper, 2022 · strength 0.12
  19. Jennifer Anne Dorth · 1 shared paper, 2016 · strength 0.08
  20. Suzanne M. Russo · 1 shared paper, 2016 · strength 0.08
  21. John Brian Ammori · 1 shared paper, 2016 · strength 0.08
  22. Alok A. Khorana · 1 shared paper, 2016 · strength 0.05
  23. Milind M. Javle · 1 shared paper, 2016 · strength 0.05
  24. Edward P. Balaban · 1 shared paper, 2016 · strength 0.05
  25. Anitra Engebretson · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.